Enhertu (trastuzumab deruxtecan), a HER2-directed antibody drug conjugate (ADC), is approved in the US and several other countries for HER2-positive advanced gastric cancer. Enhertu is jointly ...
Accenture has formed a six-year partnership with The R&A that appoints the company as the governing body’s Official Business and Technology Consulting Partner while also making it an Official Patron ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results